HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
|
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
下载
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [31] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xu, Xia
    Wang, Yan
    Wang, Fang
    Jia, Lizhou
    Zhou, Yiqin
    Deng, Fei
    Qu, Junwei
    Zhou, Bifang
    Meng, Aifeng
    Fu, Bole
    Chen, Xiaoxiang
    Qian, Zhiying
    Wang, Jinhua
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [32] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xia Xu
    Yan Wang
    Fang Wang
    Lizhou Jia
    Yiqin Zhou
    Fei Deng
    Junwei Qu
    Bifang Zhou
    Aifeng Meng
    Bole Fu
    Xiaoxiang Chen
    Zhiying Qian
    Jinhua Wang
    Journal of Ovarian Research, 6
  • [33] THE DIAGNOSTIC VALIDITY OF THE TUMOR-MARKER CA-125 IN OVARIAN-CANCER PATIENTS
    SEVELDA, P
    SALZER, H
    DITTRICH, C
    PATEISKY, N
    SPONA, J
    TUMORDIAGNOSTIK & THERAPIE, 1987, 8 (03) : 115 - 120
  • [34] CA-125 IN MONITORING CHEMOTHERAPY OF PATIENTS WITH OVARIAN-CANCER - EARLY RESPONSE TO THE TREATMENT
    MARKOWSKA, J
    KOPCZYNSKI, Z
    MANYS, G
    SZEWIERSKI, Z
    NEOPLASMA, 1990, 37 (06) : 687 - 692
  • [35] THE VALUE OF CA-125 SERUM ASSAY IN THE MANAGEMENT OF OVARIAN-CANCER
    LAMBERT, J
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (03): : 193 - 195
  • [36] CA-125 AUC as a new prognostic factor for patients with ovarian cancer
    Mano, A
    Falcao, A
    Godinho, I
    Santos, J
    Leitao, F
    Oliveira, C
    Caramona, M
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 529 - 534
  • [37] MONITORING ADVANCED NONMUCINOUS OVARIAN-CANCER BY DETERMINATIONS OF CA-125
    HOGBERG, T
    HEDIN, A
    TUMOUR BIOLOGY, 1985, 6 (04): : 423 - 423
  • [38] CA-125 AS A TUMOR-MARKER IN EPITHELIAL OVARIAN-CANCER
    SHEEHAN, JD
    DUFFY, MJ
    ALLEN, MA
    FENNELLY, JJ
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (01) : 10 - 13
  • [39] PREDICTIVE VALUE OF CA-125 LEVELS IN ADVANCED OVARIAN-CANCER
    PATSNER, B
    DAY, TG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (02) : 440 - 441
  • [40] IS CA-125 ACTUALLY A TUMOR-MARKER FOR OVARIAN-CANCER
    COLLAZOS, J
    ACTA ONCOLOGICA, 1995, 34 (02) : 268 - 268